An AllTrials project

NCT06424977: An ongoing trial by Cadence Neuroscience

This trial is ongoing. It must report results 3 years, 3 months from now.

Full data

Full entry on ClinicalTrials.gov NCT06424977
Title Safety and Effectiveness of Biomarker Targeted Stimulation in Epilepsy
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Sept. 1, 2025
Completion date Dec. 1, 2027
Required reporting date Nov. 30, 2028, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Aug. 26, 2025
Days late None